- Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial June 15, 2018
- Stem cell modeling of mitochondrial parkinsonism reveals key functions of OPA1 June 10, 2018
- LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages June 5, 2018
- The nature and nurture of cell heterogeneity: Accounting for macrophage gene-environment interactions with single-cell RNA-Seq May 30, 2018
- Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages April 29, 2018
Research Assistant | firstname.lastname@example.org
Jane Vowles joined the Oxford University Dunn School of Pathology in 2010 as a research assistant generating iPS cells from Parkinson’s Disease patients as part of a large scale Oxford Parkinson’s Disease Centre research programme funded by Parkinson’s UK.
She graduated in Agriculture from Reading University in 1981 and began her career working on reproductive physiology of ruminants at the Agricultural Production Research Unit at Reading.
She set up and ran a dairy farming business focusing on using high welfare standards to improve efficiency. During this period she maintained her research interests working in the development department of a small biotechnology company, TSC Cellworks now part of Caltag Medsystems, specialising in cell culture models as replacements for animals in research where she gained extensive primary human cell culture experience.
To broaden her experience she moved to MRC Mammalian Genetics Unit, Harwell as a microinjectionist and culturing mouse ES cells.